KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $85,000.

  • Idexx Laboratories' Gains from Investment Securities fell 61.01% to $85,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year decrease of 31.55%. This contributed to the annual value of $10.5 million for FY2024, which is 5.57% up from last year.
  • Latest data reveals that Idexx Laboratories reported Gains from Investment Securities of $85,000 as of Q3 2025, which was down 91.24% from $970,000 recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Gains from Investment Securities registered a high of $15.0 million during Q1 2021, and its lowest value of -$31,000 during Q2 2021.
  • For the 3-year period, Idexx Laboratories' Gains from Investment Securities averaged around $2.5 million, with its median value being $218,000 (2024).
  • As far as peak fluctuations go, Idexx Laboratories' Gains from Investment Securities slumped by 148.44% in 2021, and later surged by 1,127.85% in 2025.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Gains from Investment Securities stood at $61,000 in 2021, then decreased by 11.48% to $54,000 in 2022, then grew by 25.93% to $68,000 in 2023, then slumped by 33.82% to $45,000 in 2024, then plummeted by 61.01% to $85,000 in 2025.
  • Its Gains from Investment Securities was $85,000 in Q3 2025, compared to $970,000 in Q2 2025 and $6.1 million in Q1 2025.